| Year |
Citation |
Score |
| 2024 |
Li S, Wong A, Sun H, Bhatia V, Javier G, Jana S, Wu Q, Montgomery RB, Wright JL, Lam HM, Hsieh AC, Faltas BM, Haffner MC, Lee JK. A combinatorial genetic strategy for exploring complex genotype-phenotype associations in cancer. Nature Genetics. PMID 38424461 DOI: 10.1038/s41588-024-01674-1 |
0.315 |
|
| 2023 |
Mishra R, Blinka S, Hsieh AC. Citron Kinase Is a Druggable Target in Treatment-Resistant Prostate Cancer. Cancer Research. 83: 4008-4009. PMID 38098450 DOI: 10.1158/0008-5472.CAN-23-2858 |
0.333 |
|
| 2023 |
Li S, Wong A, Sun H, Bhatia V, Javier G, Jana S, Montgomery RB, Wright JL, Lam HM, Hsieh AC, Faltas BM, Haffner MC, Lee JK. Combinatorial genetic strategy accelerates the discovery of cancer genotype-phenotype associations. Biorxiv : the Preprint Server For Biology. PMID 37609344 DOI: 10.1101/2023.04.12.536652 |
0.318 |
|
| 2022 |
Germanos AA, Arora S, Zheng Y, Goddard ET, Coleman IM, Ku AT, Wilkinson S, Song H, Brady NJ, Amezquita RA, Zager M, Long A, Yang YC, Bielas JH, Gottardo R, ... ... Hsieh AC, et al. Defining cellular population dynamics at single-cell resolution during prostate cancer progression. Elife. 11. PMID 36511483 DOI: 10.7554/eLife.79076 |
0.329 |
|
| 2022 |
Kim YS, Hsieh AC, Lam HM. Bladder Cancer Patient-derived Organoids and Avatars for Personalized Cancer Discovery. European Urology Focus. PMID 35915037 DOI: 10.1016/j.euf.2022.07.006 |
0.356 |
|
| 2021 |
Jana S, Deo R, Hough RP, Liu Y, Horn JL, Wright JL, Lam HM, Webster KR, Chiang GG, Sonenberg N, Hsieh AC. mRNA translation is a therapeutic vulnerability necessary for bladder epithelial transformation. Jci Insight. 6. PMID 34032633 DOI: 10.1172/jci.insight.144920 |
0.319 |
|
| 2021 |
Cai EY, Garcia J, Liu Y, Vakar-Lopez F, Arora S, Nguyen HM, Lakely B, Brown L, Wong A, Montgomery B, Lee JK, Corey E, Wright JL, Hsieh AC, Lam HM. A bladder cancer patient-derived xenograft displays aggressive growth dynamics in vivo and in organoid culture. Scientific Reports. 11: 4609. PMID 33633154 DOI: 10.1038/s41598-021-83662-7 |
0.316 |
|
| 2019 |
Liu Y, Horn JL, Banda K, Goodman AZ, Lim Y, Jana S, Arora S, Germanos AA, Wen L, Hardin WR, Yang YC, Coleman IM, Tharakan RG, Cai EY, Uo T, ... ... Hsieh AC, et al. The androgen receptor regulates a druggable translational regulon in advanced prostate cancer. Science Translational Medicine. 11. PMID 31366581 DOI: 10.1126/scitranslmed.aaw4993 |
0.305 |
|
| 2019 |
Labrecque MP, Coleman IM, Brown LG, True LD, Kollath L, Lakely B, Nguyen HM, Yang YC, Gil da Costa RM, Kaipainen A, Coleman R, Higano CS, Yu EY, Cheng HH, Mostaghel EA, ... ... Hsieh AC, et al. Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer. The Journal of Clinical Investigation. 130. PMID 31361600 DOI: 10.1172/Jci128212 |
0.311 |
|
| 2018 |
Nguyen HG, Conn CS, Kye Y, Xue L, Forester CM, Cowan JE, Hsieh AC, Cunningham JT, Truillet C, Tameire F, Evans MJ, Evans CP, Yang JC, Hann B, Koumenis C, et al. Development of a stress response therapy targeting aggressive prostate cancer. Science Translational Medicine. 10. PMID 29720449 DOI: 10.1126/Scitranslmed.Aar2036 |
0.331 |
|
| 2018 |
Lam H, Vakar-Lopez F, Hsieh AC, Corey E, Montgomery RB, Wright JL. Bladder cancer rapid autopsy: A mechanism for collecting metastatic tumor tissue and establishing xenograft models of metastatic disease. Journal of Clinical Oncology. 36: 478-478. DOI: 10.1200/JCO.2018.36.6_SUPPL.478 |
0.342 |
|
| 2015 |
Hsieh AC, Nguyen HG, Wen L, Edlind MP, Carroll PR, Kim W, Ruggero D. Cell type-specific abundance of 4EBP1 primes prostate cancer sensitivity or resistance to PI3K pathway inhibitors. Science Signaling. 8: ra116. PMID 26577921 DOI: 10.1126/Scisignal.Aad5111 |
0.301 |
|
| 2015 |
Sheridan CM, Grogan TR, Nguyen HG, Galet C, Rettig MB, Hsieh AC, Ruggero D. YB-1 and MTA1 protein levels and not DNA or mRNA alterations predict for prostate cancer recurrence. Oncotarget. 6: 7470-80. PMID 25797255 DOI: 10.18632/Oncotarget.3477 |
0.323 |
|
| 2014 |
Edlind MP, Hsieh AC. PI3K-AKT-mTOR signaling in prostate cancer progression and androgen deprivation therapy resistance Asian Journal of Andrology. 16: 378-386. PMID 24759575 DOI: 10.4103/1008-682X.122876 |
0.303 |
|
| 2012 |
Hsieh AC, Liu Y, Edlind MP, Ingolia NT, Janes MR, Sher A, Shi EY, Stumpf CR, Christensen C, Bonham MJ, Wang S, Ren P, Martin M, Jessen K, Feldman ME, et al. The translational landscape of mTOR signalling steers cancer initiation and metastasis. Nature. 485: 55-61. PMID 22367541 DOI: 10.1038/Nature10912 |
0.366 |
|
| 2007 |
Hsieh AC, Small EJ, Ryan CJ. Androgen-response elements in hormone-refractory prostate cancer: implications for treatment development. The Lancet. Oncology. 8: 933-9. PMID 17913662 DOI: 10.1016/S1470-2045(07)70316-9 |
0.324 |
|
| Show low-probability matches. |